
Departamento de Clinica Medica Faculdade de Medicina de Botucatu Universidade Estadual Paulista Julio de Mesquista Filho-UNESP
Vascular Endothelial Growth Factor A, Pioglitazone, Pioglitazone, Diabetes Mellitus/drug therapy, Vascular Endothelial Growth Factor Receptor-2, Peroxisome Proliferators/adverse effects, RC666-701, Glucose/metabolism, Diseases of the circulatory (Cardiovascular) system, Lipids/metabolism, Lipídeos/metabolism, Thiazolidinediones, Proliferadores de Peroxissomos/efeitos adversos, Diabetes Mellitus/tratamento farmacológico, Short Editorial, Pioglitazona, Signal Transduction
Vascular Endothelial Growth Factor A, Pioglitazone, Pioglitazone, Diabetes Mellitus/drug therapy, Vascular Endothelial Growth Factor Receptor-2, Peroxisome Proliferators/adverse effects, RC666-701, Glucose/metabolism, Diseases of the circulatory (Cardiovascular) system, Lipids/metabolism, Lipídeos/metabolism, Thiazolidinediones, Proliferadores de Peroxissomos/efeitos adversos, Diabetes Mellitus/tratamento farmacológico, Short Editorial, Pioglitazona, Signal Transduction
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 1 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
